Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo

Immunobiology

Volumn 220, Issue 2, 2015, Pages 270-279

  Kreiser, Simon ^a   Eckhardt, Jenny ^a   Kuhnt, Christine ^a   Stein, Marcello ^a   Krzyzak, Lena ^a   Seitz, Christine ^a   Tucher, Christine ^a   Knippertz, Ilka ^a   Becker, Christoph ^a   Günther, Claudia ^a   Steinkasserer, Alexander ^a   Lechmann, Matthias ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

CD83; Suppression; T cell; Transfer colitis; Treg

Indexed keywords

CD38 ANTIGEN; CELL PROTEIN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; HELIOS PROTEIN; INTERLEUKIN 2 RECEPTOR ALPHA; NEUROPILIN 1; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; CD83 ANTIGEN; HOMEODOMAIN PROTEIN; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; RAG-1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CD83+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE CONTROL; EFFECTOR CELL; GENE INDUCTION; GLUCOCORTICOID INDUCED TNFR FAMILY RELATED GENE; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SYMPTOM; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; BLOOD; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC MEMORY; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PHENOTYPE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84926416257     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.08.005     Document Type: Article

References (58)

1. Akimova T., Beier U.H., Wang L., Levine M.H., Hancock W.W. Helios expression is a marker of T cell activation and proliferation. PLoS ONE 2011, 6:e24226.
2. Becker C., Fantini M.C., Neurath M.F. High resolution colonoscopy in live mice. Nat. Protoc. 2006, 1(6):2900-2904.
3. Becker C., Fantini M.C., Wirtz S., Nikolaev A., Kiesslich R., Lehr H.A., Galle P.R., Neurath M.F. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut 2005, 54:950-954.
4. Beriou G., Costantino C.M., Ashley C.W., Yang L., Kuchroo V.K., Baecher-Allan C., Hafler D.A. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009, 113:4240-4249.
5. Bock F., Rossner S., Onderka J., Lechmann M., Pallotta M.T., Fallarino F., Boon L., Nicolette C., DeBenedette M.A., Tcherepanova I.Y., Grohmann U., Steinkasserer A., Cursiefen C., Zinser E. Topical application of soluble CD83 induces IDO-mediated immune modulation, increases Foxp3+ T cells, and prolongs allogeneic corneal graft survival. J. Immunol. 2013, 191:1965-1975.
6. Breloer M., Kretschmer B., Luthje K., Ehrlich S., Ritter U., Bickert T., Steeg C., Fillatreau S., Hoehlig K., Lampropoulou V., Fleischer B. CD83 is a regulator of murine B cell function in vivo. Eur. J. Immunol. 2007, 37:634-648.
7. Bruder D., Probst-Kepper M., Westendorf A.M., Geffers R., Beissert S., Loser K., von B.H., Buer J., Hansen W. Neuropilin-1: a surface marker of regulatory T cells. Eur. J. Immunol. 2004, 34:623-630.
8. Cebula A., Seweryn M., Rempala G.A., Pabla S.S., McIndoe R.A., Denning T.L., Bry L., Kraj P., Kisielow P., Ignatowicz L. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature 2013, 497:258-262.
9. Collison L.W., Vignali D.A. In vitro Treg suppression assays. Methods Mol. Biol. 2011, 707:21-37.
10. Coombes J.L., Siddiqui K.R., Arancibia-Carcamo C.V., Hall J., Sun C.M., Belkaid Y., Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 2007, 204:1757-1764.
11. Cramer S.O., Trumpfheller C., Mehlhoop U., More S., Fleischer B., von B.A. Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells. Int. Immunol. 2000, 12:1347-1351.
12. Dudziak D., Nimmerjahn F., Bornkamm G.W., Laux G. Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation. J. Immunol. 2005, 174:6672-6676.
13. Eckhardt J., Kreiser S., Dobbeler M., Nicolette C., DeBenedette M.A., Tcherepanova I.Y., Ostalecki C., Pommer A.J., Becker C., Gunther C., Zinser E., Mak T.W., Steinkasserer A., Lechmann M. Soluble CD83 ameliorates experimental colitis in mice. Mucosal. Immunol. 2014.
14. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4:330-336.
15. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22:329-341.
16. Fujimoto Y., Tu L., Miller A.S., Bock C., Fujimoto M., Doyle C., Steeber D.A., Tedder T.F. CD83 expression influences CD4+ T cell development in the thymus. Cell 2002, 108:755-767.
17. Garcia-Martinez L.F., Appleby M.W., Staehling-Hampton K., Andrews D.M., Chen Y., McEuen M., Tang P., Rhinehart R.L., Proll S., Paeper B., Brunkow M.E., Grandea A.G., Howard E.D., Walker D.E., Charmley P., Jonas M., Shaw S., Latham J.A., Ramsdell F. A novel mutation in CD83 results in the development of a unique population of CD4+ T cells. J. Immunol. 2004, 173:2995-3001.
18. Ge W., Arp J., Lian D., Liu W., Baroja M.L., Jiang J., Ramcharran S., Eldeen F.Z., Zinser E., Steinkasserer A., Chou P., Brand S., Nicolette C., Garcia B., Wang H. Immunosuppression involving soluble CD83 induces tolerogenic dendritic cells that prevent cardiac allograft rejection. Transplantation 2010, 90:1145-1156.
19. Glinka Y., Prud'homme G.J. Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J. Leukoc. Biol. 2008, 84:302-310.
20. Gottschalk R.A., Corse E., Allison J.P. Expression of Helios in peripherally induced Foxp3+ regulatory T cells. J. Immunol. 2012, 188:976-980.
21. Han Y., Guo Q., Zhang M., Chen Z., Cao X. CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta1. J. Immunol. 2009, 182:111-120.
22. Hock B.D., Kato M., McKenzie J.L., Hart D.N. A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera. Int. Immunol. 2001, 13:959-967.
23. Hock B.D., Haring L.F., Steinkasserer A., Taylor K.G., Patton W.N., McKenzie J.L. The soluble form of CD83 is present at elevated Levels in a number of hematological malignancies. Leuk. Res. 2004, 28:237-241.
24. Hoffmann P., Eder R., Edinger M. Polyclonal expansion of human CD4(+)CD25(+) regulatory T cells. Methods Mol. Biol. 2011, 677:15-30.
25. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
26. Kim B.S., Kim I.K., Park Y.J., Kim Y.S., Kim Y.J., Chang W.S., Lee Y.S., Kweon M.N., Chung Y., Kang C.Y. Conversion of Th2 memory cells into Foxp3+ regulatory T cells suppressing Th2-mediated allergic asthma. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:8742-8747.
27. Lan Z., Lian D., Liu W., Arp J., Charlton B., Ge W., Brand S., Healey D., DeBenedette M., Nicolette C., Garcia B., Wang H. Prevention of chronic renal allograft rejection by soluble CD83. Transplantation 2010, 90:1278-1285.
28. Lechmann M., Krooshoop D.J., Dudziak D., Kremmer E., Kuhnt C., Figdor C.G., Schuler G., Steinkasserer A. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J. Exp. Med. 2001, 194:1813-1821.
29. Lechmann M., Shuman N., Wakeham A., Mak T.W. The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11887-11892.
30. Lu S.Y., Huang X.J., Liu K.Y., Liu D.H., Xu L.P. High frequency of CD4+ CD25- CD69+ T cells is correlated with a low risk of acute graft-versus-host disease in allotransplants. Clin. Transplant. 2012, 26:E158-E167.
31. Martin P., Gomez M., Lamana A., Cruz-Adalia A., Ramirez-Huesca M., Ursa M.A., Yanez-Mo M., Sanchez-Madrid F. CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation. Mol. Cell. Biol. 2010, 30:4877-4889.
32. McClymont S.A., Putnam A.L., Lee M.R., Esensten J.H., Liu W., Hulme M.A., Hoffmuller U., Baron U., Olek S., Bluestone J.A., Brusko T.M. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 2011, 186:3918-3926.
33. Mombaerts P., Iacomini J., Johnson R.S., Herrup K., Tonegawa S., Papaioannou V.E. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992, 68:869-877.
34. Prazma C.M., Yazawa N., Fujimoto Y., Fujimoto M., Tedder T.F. CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo. J. Immunol. 2007, 179:4550-4562.
35. Prechtel A.T., Steinkasserer A. CD83: an update on functions and prospects of the maturation marker of dendritic cells. Arch. Dermatol. Res. 2007, 299:59-69.
36. Reinwald S., Wiethe C., Westendorf A.M., Breloer M., Probst-Kepper M., Fleischer B., Steinkasserer A., Buer J., Hansen W. CD83 expression in CD4+ T cells modulates inflammation and autoimmunity. J. Immunol. 2008, 180:5890-5897.
37. Sakaguchi S., Setoguchi R., Yagi H., Nomura T. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease. Curr. Top. Microbiol. Immunol. 2006, 305:51-66.
38. Sancho D., Gomez M., Sanchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 2005, 26:136-140.
39. Sancho D., Gomez M., Viedma F., Esplugues E., Gordon-Alonso M., Garcia-Lopez M.A., de la Fuente H., Martinez A., Lauzurica P., Sanchez-Madrid F. CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. J. Clin. Invest. 2003, 112:872-882.
40. Santis A.G., Campanero M.R., Alonso J.L., Tugores A., Alonso M.A., Yague E., Pivel J.P., Sanchez-Madrid F. Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway. Eur. J. Immunol. 1992, 22:1253-1259.
41. Scholler N., Hayden-Ledbetter M., Dahlin A., Hellstrom I., Hellstrom K.E., Ledbetter J.A. Cutting edge: CD83 regulates the development of cellular immunity. J. Immunol. 2002, 168:2599-2602.
42. Senechal B., Boruchov A.M., Reagan J.L., Hart D.N., Young J.W. Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood 2004, 103:4207-4215.
43. Shiow L.R., Rosen D.B., Brdickova N., Xu Y., An J., Lanier L.L., Cyster J.G., Matloubian M. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006, 440:540-544.
44. Stein M.F., Lang S., Winkler T.H., Deinzer A., Erber S., Nettelbeck D.M., Naschberger E., Jochmann R., Sturzl M., Slany R.K., Werner T., Steinkasserer A., Knippertz I. Multiple interferon regulatory factor and NF-kappaB sites cooperate in mediating cell-type- and maturation-specific activation of the human CD83 promoter in dendritic cells. Mol. Cell. Biol. 2013, 33:1331-1344.
45. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., Belkaid Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 Treg cells via retinoic acid. J. Exp. Med. 2007, 204:1775-1785.
46. Takebayashi K., Koboziev I., Ostanin D.V., Gray L., Karlsson F., Robinson-Jackson S.A., Kosloski-Davidson M., Dooley A.B., Zhang S., Grisham M.B. Role of the gut-associated and secondary lymphoid tissue in the induction of chronic colitis. Inflamm. Bowel Dis. 2011, 17:268-278.
47. Thornton A.M., Korty P.E., Tran D.Q., Wohlfert E.A., Murray P.E., Belkaid Y., Shevach E.M. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 2010, 184:3433-3441.
48. Valmori D., Raffin C., Raimbaud I., Ayyoub M. Human RORgammat+ TH17 cells preferentially differentiate from naive FOXP3+ Treg in the presence of lineage-specific polarizing factors. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:19402-19407.
49. Weiss J.M., Bilate A.M., Gobert M., Ding Y., Curotto de Lafaille M.A., Parkhurst C.N., Xiong H., Dolpady J., Frey A.B., Ruocco M.G., Yang Y., Floess S., Huehn J., Oh S., Li M.O., Niec R.E., Rudensky A.Y., Dustin M.L., Littman D.R., Lafaille J.J. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 2012, 209:1723-1742. S1.
50. Wolenski M., Cramer S.O., Ehrlich S., Steeg C., Grossschupff G., Tenner-Racz K., Racz P., Fleischer B., von B.A. Expression of CD83 in the murine immune system. Med. Microbiol. Immunol. 2003, 192:189-192.
51. Xu J.F., Huang B.J., Yin H., Xiong P., Feng W., Xu Y., Fang M., Zheng F., Wang C.Y., Gong F.L. A limited course of soluble CD83 delays acute cellular rejection of MHC-mismatched mouse skin allografts. Transpl. Int. 2007, 20:266-276.
52. Yadav M., Louvet C., Davini D., Gardner J.M., Martinez-Llordella M., Bailey-Bucktrout S., Anthony B.A., Sverdrup F.M., Head R., Kuster D.J., Ruminski P., Weiss D., Von S.D., Bluestone J.A. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J. Exp. Med. 2012, 209:1713-1719.
53. Zhao Q., Kang D.M., Wu Y., Li X.F., Li T.J., Zheng L. Activated CD69+ T cells foster immune privilege by regulating IDO Expression in tumor-associated macrophages. J. Immunol. 2012, 188:1117-1124.
54. Zheng Y., Manzotti C.N., Burke F., Dussably L., Qureshi O., Walker L.S., Sansom D.M. Acquisition of suppressive function by activated human CD4+CD25- T cells is associated with the expression of CTLA-4 not FoxP3. J. Immunol. 2008, 181:1683-1691.
55. Zhou L.J., Tedder T.F. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 1995, 154:3821-3835.
56. Zhou L.J., Tedder T.F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:2588-2592.
57. Ziegler S.F. FOXP3: of mice and men. Annu. Rev. Immunol. 2006, 24:209-226.
58. Zinser E., Lechmann M., Golka A., Lutz M.B., Steinkasserer A. Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J. Exp. Med. 2004, 200:345-351.